日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II Trial

采用个性化给药间隔的 Efdamrofusp Alfa 治疗新生血管性年龄相关性黄斑变性的疗效和安全性：一项 II 期试验

期刊:Ophthalmology Science
影响因子:4.6
doi:10.1016/j.xops.2025.100913
Li, Tong; Yang, Shiqi; Liu, Qinghuai; Song, Yanping; Tong, Jianping; Wei, Wenbin; Chen, Weiqi; Dai, Hong; Wang, Wei; Wu, Miaoqin; Zhou, Guohong; Xiao, Xuan; Zhang, Jinglin; Zhu, Rongrong; Li, Haoyu; Wang, Yafang; Chen, Xiaoyu; Lu, Shujie; Du, Haiwei; Han-Zhang, Han; Hao, Jilong; Li, Chaopeng; Wen, Ying; Zhang, Jie; Sun, Junran; Jia, Huixun; Sun, Xiaodong
发表日期：2026
文献求助 收藏

Xijiao Dihuang Decoction for Sepsis-Induced Acute Lung Injury: Network Pharmacology and Molecular Dynamics Insights.

西交地黄汤治疗脓毒症引起的急性肺损伤：网络药理学和分子动力学见解

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S506444
Xu Jiaqi, Jiao Conghan, Du Haiwei, Guo Xiaojing, Wang Mutian, Ma Yuening, Yin Yanzhong, Liu Min, Shao Rongjiang
毒理研究
发表日期：2025
文献求助 收藏

Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients

对NGS panel在检测转移性非小细胞肺癌患者ctDNA中可靶向变异方面的分析和临床验证

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70078
Fan, Feifei; Jiang, Guozhong; Lv, Juan; Wang, Hongmin; Li, Wenjie; Liu, Chenglin; Zhao, Yu; Zhang, Zhou; Du, Haiwei; Zhang, Zhihong; Li, Xiangnan; Li, Wen-Cai
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Engineering graphitic carbon nitride for next-generation photodetectors: a mini review

用于下一代光电探测器的工程化石墨氮化碳：简要综述

期刊:RSC Advances
影响因子:4.6
doi:10.1039/d3ra04051h
Li, Yuan; Du, Haiwei
发表日期：2023
文献求助 收藏

Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non-small-cell lung cancer.

肿瘤免疫微环境可预测非小细胞肺癌新辅助化疗免疫疗法的病理反应

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15778
Han Rui, Zhang Yimin, Wang Tianhu, Xiao Hualiang, Luo Zhilin, Shen Cheng, Li Jianghua, Zhao Chenglong, Li Li, Zhu Mengxiao, Du Haiwei, Tang Huan, Ma Zheng, Wang Yubo, He Yong
肿瘤
肺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

The rational application of liquid biopsy based on next-generation sequencing in advanced non-small cell lung cancer

基于二代测序的液体活检在晚期非小细胞肺癌中的合理应用

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5410
Zhao, Chenglong; Li, Jianghua; Zhang, Yongchang; Han, Rui; Wang, Yubo; Li, Li; Zhang, Yimin; Zhu, Mengxiao; Zheng, Jie; Du, Haiwei; Hu, Chen; Zhou, Chengzhi; Yang, Nong; Cai, Shangli; He, Yong
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma

鉴定六种激素分泌相关基因特征作为结肠腺癌的预后生物标志物

期刊:Cancer Biomarkers
影响因子:1.9
doi:10.3233/CBM-230126
Jia, Xiongjie; Zhang, Tao; Lv, Xinze; Du, Haiwei; Sun, Yongkun; Guan, Yin
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

A lung squamous cell carcinoma-associated membranous nephropathy patient free of tumor and membranous nephropathy after the treatment of surgery and radiochemotherapy following pembrolizumab: A rare case report

一例罕见病例报告：肺鳞状细胞癌相关膜性肾病患者在接受手术、放化疗及帕博利珠单抗治疗后，肿瘤和膜性肾病均消失。

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000032508
Chen, Feifei; Du, Haiwei; Fang, Surong
肿瘤免疫
细胞生物学
肿瘤
发表日期：2023
文献求助 收藏

Kinesin superfamily member KIFC2 as an independent prognostic biomarker of colon adenocarcinoma associated with poor immune response

驱动蛋白超家族成员KIFC2作为结肠腺癌的独立预后生物标志物，与免疫反应不良相关

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000035491
Chen, Tao; Chu, Yunqian; Xu, Haiyuan; Dai, Hanjue; Zhou, Yuxi; Du, Haiwei; Zhu, Wenyu
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Comprehensive genomic profiling and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the stomach and parotid gland

胃和腮腺原发性淋巴上皮瘤样癌的全面基因组分析及PD-L1表达检测。

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-21-5908
Cui, Qian; Wu, Hongmei; Zeng, Wenrong; Du, Haiwei; Xiao, Zebin; Hou, Ting; Li, Min; Li, Yuan; Zhang, Zhou; Li, Zhi
PD-L1
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏